Ask AI

Shifting Gears in Cardio–Renal–Metabolic Care: Harnessing Evidenced-Based Therapies to Optimize Patient Outcomes

Deepen your understanding of the latest evidence for SGLT2 inhibitors and other novel therapies to treat cardio–renal–metabolic (CRM) syndrome. Then gain strategies for addressing persistent gaps in CRM care and counseling patients regarding their personalized care plans through expert-written ClinicalThought commentaries, downloadable slides, and an on-demand webcast.

Share

Program Content

Events

Activities

Optimizing CKM Syndrome Care
Optimizing CKM Syndrome Care: Strategies for Employing Evidence-Based, Guideline-Recommended Therapies
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 16, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

Supporters

Supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

Boehringer Ingelheim Pharmaceuticals, Inc.

Eli Lilly and Company